nitrates has been researched along with Peritonitis in 23 studies
Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.
Peritonitis: INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Arginine deficiency and chronic inflammation may cause immune dysfunction." | 7.78 | Appropriate dose of parenteral arginine enhances immunity of peripheral blood cells and splenocytes in rats with subacute peritonitis. ( Chen, YH; Hsiao, CC; Hsu, LS; Lee, CH; Lo, HC, 2012) |
| "Chronic inflammation accompanied by arginine deficiency, immune dysfunction, and excess nitric oxide (NO) production is a clinical condition found in patients with peritonitis." | 7.78 | The dose-dependent immunoregulatory effects of the nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl ester in rats with sub-acute peritonitis. ( Hsiao, CC; Lee, CH; Lo, HC; Tsao, LY, 2012) |
| "To investigate the effects of glutamine (GLN)-enriched diets before and GLN-containing total parenteral nutrition (TPN) after sepsis or both on the secretion of cytokines and their mRNA expression levels in splenocytes of rats with septic peritonitis." | 7.73 | Effects of glutamine supplementation on splenocyte cytokine mRNA expression in rats with septic peritonitis. ( Chen, WJ; Chiu, WC; Lai, YN; Lin, MT; Shang, HF; Yeh, SL, 2005) |
| "Peritonitis was induced by a single injection of zymosan A or zymosan supplemented with morphine in Swiss mice." | 5.38 | Toll-like receptors expression and NF-κB activation in peritoneal leukocytes in morphine-mediated impairment of zymosan-induced peritonitis in swiss mice. ( Kołaczkowska, E; Mazur, AI; Natorska, J; Wypasek, E, 2012) |
| "Arginine deficiency and chronic inflammation may cause immune dysfunction." | 3.78 | Appropriate dose of parenteral arginine enhances immunity of peripheral blood cells and splenocytes in rats with subacute peritonitis. ( Chen, YH; Hsiao, CC; Hsu, LS; Lee, CH; Lo, HC, 2012) |
| "Chronic inflammation accompanied by arginine deficiency, immune dysfunction, and excess nitric oxide (NO) production is a clinical condition found in patients with peritonitis." | 3.78 | The dose-dependent immunoregulatory effects of the nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl ester in rats with sub-acute peritonitis. ( Hsiao, CC; Lee, CH; Lo, HC; Tsao, LY, 2012) |
| "To investigate the effects of glutamine (GLN)-enriched diets before and GLN-containing total parenteral nutrition (TPN) after sepsis or both on the secretion of cytokines and their mRNA expression levels in splenocytes of rats with septic peritonitis." | 3.73 | Effects of glutamine supplementation on splenocyte cytokine mRNA expression in rats with septic peritonitis. ( Chen, WJ; Chiu, WC; Lai, YN; Lin, MT; Shang, HF; Yeh, SL, 2005) |
| " Thus, the objective of this study was to assess the role of iNOS in modulating neutrophil (PMN) extravasation in an oyster glycogen-induced model of acute peritonitis in rats." | 3.70 | Role of inducible nitric oxide synthase in leukocyte extravasation in vivo. ( Cockrell, A; Gray, L; Grisham, MB; Jourd'heuil, D; Kawachi, S; Laroux, FS; Van der Heyde, H, 1999) |
| " In vivo treatment with ip administration of 3-aminobenzamide (10 mg/kg, 1 and 6 hrs after zymosan injection) or nicotinamide (50 mg/kg, 1 and 6 hrs after zymosan injection) significantly decreased mortality, inhibited the development of peritonitis, and reduced peroxynitrite formation." | 3.70 | Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ failure after zymosan-induced peritonitis in the rat. ( Caputi, AP; Costantino, G; Cuzzocrea, S; Sottile, A; Teti, D; Zingarelli, B, 1999) |
| "Peritonitis was induced by a single injection of zymosan A or zymosan supplemented with morphine in Swiss mice." | 1.38 | Toll-like receptors expression and NF-κB activation in peritoneal leukocytes in morphine-mediated impairment of zymosan-induced peritonitis in swiss mice. ( Kołaczkowska, E; Mazur, AI; Natorska, J; Wypasek, E, 2012) |
| "MODS was induced by zymosan administration (500 mg/kg, suspended in saline solution, i." | 1.35 | Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome. ( Bramanti, P; Caminiti, R; Cuzzocrea, S; Di Paola, R; Esposito, E; Genovese, T; Malleo, G; Mazzon, E, 2008) |
| "Although sepsis is the major cause of mortality and morbidity in the critically ill, precise mechanism(s) causing multiorgan dysfunction remain unclear." | 1.32 | Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. ( Brealey, D; Jacques, TS; Karyampudi, S; Novelli, M; Singer, M; Smolenski, RT; Stidwill, R; Taylor, V, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (52.17) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 7 (30.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boccella, S | 1 |
| Panza, E | 1 |
| Lista, L | 1 |
| Belardo, C | 1 |
| Ianaro, A | 1 |
| De Rosa, M | 1 |
| de Novellis, V | 1 |
| Pavone, V | 1 |
| Amoruso, A | 1 |
| Fresu, LG | 1 |
| Dalli, J | 1 |
| Miglietta, D | 1 |
| Bardelli, C | 1 |
| Federici Canova, D | 1 |
| Perretti, M | 1 |
| Brunelleschi, S | 1 |
| Lo, HC | 3 |
| Hung, CY | 1 |
| Huang, FH | 1 |
| Su, TC | 1 |
| Lee, CH | 3 |
| Ji, M | 1 |
| Li, R | 1 |
| Li, GM | 1 |
| Fan, Y | 1 |
| Dong, L | 1 |
| Yang, J | 1 |
| Peng, YG | 1 |
| Wu, J | 1 |
| Chen, YH | 1 |
| Hsu, LS | 1 |
| Hsiao, CC | 2 |
| Tsao, LY | 1 |
| Wypasek, E | 1 |
| Natorska, J | 1 |
| Mazur, AI | 1 |
| Kołaczkowska, E | 1 |
| Brealey, D | 1 |
| Karyampudi, S | 1 |
| Jacques, TS | 1 |
| Novelli, M | 1 |
| Stidwill, R | 1 |
| Taylor, V | 1 |
| Smolenski, RT | 1 |
| Singer, M | 1 |
| Yeh, SL | 1 |
| Lai, YN | 1 |
| Shang, HF | 1 |
| Lin, MT | 1 |
| Chiu, WC | 1 |
| Chen, WJ | 1 |
| Kikuchi, M | 1 |
| Endo, S | 1 |
| Inada, K | 1 |
| Inoue, Y | 1 |
| Wakabayashi, G | 1 |
| Ishikura, H | 1 |
| Tanaka, T | 1 |
| Malleo, G | 1 |
| Mazzon, E | 4 |
| Genovese, T | 1 |
| Di Paola, R | 1 |
| Caminiti, R | 1 |
| Esposito, E | 1 |
| Bramanti, P | 1 |
| Cuzzocrea, S | 7 |
| Douma, CE | 1 |
| de Waart, DR | 1 |
| Zemel, D | 1 |
| Imholz, AL | 1 |
| Koomen, GC | 1 |
| Struijk, DG | 1 |
| Krediet, RT | 1 |
| Yang, CW | 1 |
| Hwang, TL | 1 |
| Wu, CH | 1 |
| Lai, PC | 1 |
| Huang, JY | 1 |
| Yu, CC | 1 |
| Shyr, MH | 1 |
| Huang, CC | 1 |
| Filippelli, A | 1 |
| Zingarelli, B | 3 |
| Falciani, M | 1 |
| Caputi, AP | 6 |
| Rossi, F | 1 |
| Bories, PN | 1 |
| Campillo, B | 1 |
| Azaou, L | 1 |
| Scherman, E | 1 |
| Garcia-Tsao, G | 1 |
| Angulo, P | 1 |
| Garcia, JC | 1 |
| Groszmann, RJ | 1 |
| Cadelina, GW | 1 |
| Costantino, G | 4 |
| Strand, OA | 1 |
| Leone, AM | 1 |
| Giercksky, KE | 1 |
| Skovlund, E | 1 |
| Kirkebøen, KA | 1 |
| Cockrell, A | 1 |
| Laroux, FS | 1 |
| Jourd'heuil, D | 1 |
| Kawachi, S | 1 |
| Gray, L | 1 |
| Van der Heyde, H | 1 |
| Grisham, MB | 1 |
| de Sarro, G | 1 |
| Laurà, R | 1 |
| Ciriaco, E | 1 |
| de Sarro, A | 1 |
| Sottile, A | 1 |
| Teti, D | 1 |
| Dugo, L | 1 |
| Barbera, A | 1 |
| Centorrino, T | 1 |
| Ciccolo, A | 1 |
| Fonti, MT | 1 |
1 trial available for nitrates and Peritonitis
| Article | Year |
|---|---|
N(G)-monomethyl-L-arginine improves survival in a pig model of abdominal sepsis.
Topics: Animals; Bacteremia; Critical Care; Disease Models, Animal; Enzyme Inhibitors; Hemodynamics; Nitrate | 1998 |
22 other studies available for nitrates and Peritonitis
| Article | Year |
|---|---|
Preclinical evaluation of the urokinase receptor-derived peptide UPARANT as an anti-inflammatory drug.
Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Cyclooxygenase 2; Dexamethasone; Edema; Male; Mice; | 2017 |
Characterization of the anti-inflammatory properties of NCX 429, a dual-acting compound releasing nitric oxide and naproxen.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dinoprostone; Disease Models, Animal; Drug Evaluat | 2015 |
The Nitric Oxide Synthase Inhibitor NG-Nitro-L-Arginine Methyl Ester Diminishes the Immunomodulatory Effects of Parental Arginine in Rats with Subacute Peritonitis.
Topics: Adjuvants, Immunologic; Animals; Arginine; Body Weight; Cytokines; Immunophenotyping; Male; NG-Nitro | 2016 |
Effects of combined levosimendan and vasopressin on pulmonary function in porcine septic shock.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Drug Therapy, Combination; Female; Hemodynamics; HMG- | 2012 |
Appropriate dose of parenteral arginine enhances immunity of peripheral blood cells and splenocytes in rats with subacute peritonitis.
Topics: Animals; Arginine; Chronic Disease; Concanavalin A; Cytokines; Deficiency Diseases; Dietary Suppleme | 2012 |
The dose-dependent immunoregulatory effects of the nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl ester in rats with sub-acute peritonitis.
Topics: Acute Disease; Animals; Arginine; Body Weight; Cell Proliferation; Cytokines; Dose-Response Relation | 2012 |
Toll-like receptors expression and NF-κB activation in peritoneal leukocytes in morphine-mediated impairment of zymosan-induced peritonitis in swiss mice.
Topics: Analgesics, Opioid; Animals; Cell Line; Flow Cytometry; Keratinocytes; Leukocytes; Male; Mice; Morph | 2012 |
Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Animals; Biomarkers; Blood Pressure; Blood Urea Nit | 2004 |
Effects of glutamine supplementation on splenocyte cytokine mRNA expression in rats with septic peritonitis.
Topics: Animal Feed; Animals; Cytokines; Glutamine; Lymphocytes; Male; Nitrates; Nitrites; Peritonitis; Rats | 2005 |
Assessment of inflammatory mediators in patients with generalized peritonitis.
Topics: Adult; Aged; Aged, 80 and over; Cytokines; Endotoxins; Female; Group IV Phospholipases A2; Humans; I | 1999 |
Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome.
Topics: Animals; Gene Deletion; Interleukin-10; Interleukin-1beta; Kidney; Lipid Peroxidation; Liver; Mice; | 2008 |
Nitrate in stable CAPD patients and during peritonitis.
Topics: Acute Disease; Adult; Aged; Biological Transport; Creatinine; Dialysis Solutions; Female; Humans; Ma | 1995 |
Peritoneal nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Topics: Acinetobacter Infections; Adult; Aged; Biomarkers; Dialysis Solutions; Female; Humans; Kidney Failur | 1996 |
Role of nitric oxide in a nonseptic shock model induced by zymosan in the rat.
Topics: Acute Disease; Animals; Ascitic Fluid; Blood Pressure; Cardiovascular Diseases; Enzyme Inhibitors; M | 1997 |
Long-lasting NO overproduction in cirrhotic patients with spontaneous bacterial peritonitis.
Topics: Adult; Aged; Aged, 80 and over; Ascitic Fluid; Bacterial Infections; C-Reactive Protein; Female; Hum | 1997 |
The diagnostic and predictive value of ascites nitric oxide levels in patients with spontaneous bacterial peritonitis.
Topics: Ascites; Bacterial Infections; Creatinine; Female; Humans; Male; Middle Aged; Nitrates; Nitric Oxide | 1998 |
Protective effect of melatonin in a non-septic shock model induced by zymosan in the rat.
Topics: Acute Disease; Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Chemotaxis, Leukocyte; | 1998 |
Role of inducible nitric oxide synthase in leukocyte extravasation in vivo.
Topics: Acute Disease; Animals; Ascitic Fluid; Blotting, Western; Cell Movement; Disease Models, Animal; Enz | 1999 |
Role of interleukin-6 in a non-septic shock model induced by zymosan.
Topics: Animals; Antibodies, Monoclonal; Ascites; Ascitic Fluid; DNA Damage; Energy Metabolism; Injections, | 1999 |
Protective effect of N-acetylcysteine on multiple organ failure induced by zymosan in the rat.
Topics: Acetylcysteine; Animals; Body Weight; Disease Models, Animal; Drug Evaluation, Preclinical; Free Rad | 1999 |
Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ failure after zymosan-induced peritonitis in the rat.
Topics: Animals; Benzamides; Body Weight; Disease Models, Animal; Drug Evaluation, Preclinical; Male; Multip | 1999 |
Inducible nitric oxide synthase knockout mice exhibit resistance to the multiple organ failure induced by zymosan.
Topics: Animals; Enzyme Inhibitors; Exudates and Transudates; Guanidines; Lipid Peroxidation; Liver; Lung; M | 2001 |